Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins

Rheumatoid Arthritis

Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease

Ann Rheum Dis.

Castellanos-Moreira R, Rodríguez-García SC, Gomara MJ, Ruiz-Esquide V, Cuervo A, Casafont-Solé I, Ramírez J, Holgado S, Gómez-Puerta JA, Cañete JD, Haro I, Sanmarti R

doi: 10.1136/annrheumdis-2019-216709.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Rheumatology (Oxford).

Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium ., the ImmunoArray consortium ., Meadows JRS, Rantapää-Dahlqvist S, Mandl T, Eriksson P, Lind L, Omdal R, Jonsson R, Lindblad-Toh K, Rönnblom L, Wahren-Herlenius M, Nordmark G

doi: 10.1093/rheumatology/keaa367.

Psoriasis

Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials

Br J Dermatol.

Langley RG, Armstrong AW, Lebwohl MG, Blauvelt A, Hsu S, Tyring S, Rastogi S, Pillai R, Israel R

doi: 10.1111/bjd.17318.

Systemic SclerosisFurther Publications Rheumatology

Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: subgroup analyses by autoantibody status and skin score

Arthritis Rheumatol

Kuwana M, Allanore Y, Denton CP, Distler JH, Steen V, Khanna D, Matucci-Cerinic M, Mayes MD, Volkmann ER, Miede C, Gahlemann M, Quaresma Lic M, Alves M, Distler O

doi: 10.1002/art.41965

Further Publications Rheumatology

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Rheumatology (Oxford)

Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium ., the ImmunoArray consortium ., Meadows JRS, Rantapää-Dahlqvist S, Mandl T, Eriksson P, Lind L, Omdal R, Jonsson R, Lindblad-Toh K, Rönnblom L, Wahren-Herlenius M, Nordmark G

doi: 10.1093/rheumatology/keaa367

Immunodeficiency

Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency

J Allergy Clin Immunol.

Platt CD, Zaman F, Bainter W, Stafstrom K, Almutairi A, Reigle M, Weeks S, Geha RS, Chou J, International Consortium for Immunodeficiencies

doi: 10.1016/j.jaci.2020.08.022.

RECOMMENDED

Spinal Disorders

The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis

Semin Arthritis Rheum.

Baraliakos X, Szumski A, Koenig AS, Jones H

doi: 10.1016/j.semarthrit.

Rheumatoid Arthritis

Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status

Ann Rheum Dis.

Boeters DM, Burgers LE, Toes RE, van der Helm-van Mil A

doi: 10.1136/annrheumdis-2018-214868.

Further Publications Rheumatology

Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies

Arthritis Rheumatol

Casal-Dominguez M, Pinal-Fernandez I, Pak K, Huang W, Selva-O'Callaghan A, Albayda J, Casciola-Rosen L, Paik JJ, Tiniakou E, Mecoli CA, Lloyd TE, Danoff SK, Christopher-Stine L, Mammen AL

doi: 10.1002/art.41964

Related content

Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials

Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: subgroup analyses by autoantibody status and skin score

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency

The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis

Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status

Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies